Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chemical probes to potently and selectively inhibit endocannabinoid cellular reuptake
Andrea Chicca, Simon Nicolussi, Ruben Bartholomäus, et al.
Proceedings of the National Academy of Sciences (2017) Vol. 114, Iss. 25
Open Access | Times Cited: 91

Showing 1-25 of 91 citing articles:

New approaches and challenges to targeting the endocannabinoid system
Vincenzo Di Marzo
Nature Reviews Drug Discovery (2018) Vol. 17, Iss. 9, pp. 623-639
Closed Access | Times Cited: 409
2-Arachidonoylglycerol: A signaling lipid with manifold actions in the brain
Marc P. Baggelaar, Mauro Maccarrone, Mario van der Stelt
Progress in Lipid Research (2018) Vol. 71, pp. 1-17
Open Access | Times Cited: 188
Cannabinoid Signaling in the Skin: Therapeutic Potential of the “C(ut)annabinoid” System
Kinga Tóth, Dorottya Ádám, Tamás Bı́ró, et al.
Molecules (2019) Vol. 24, Iss. 5, pp. 918-918
Open Access | Times Cited: 176
Goods and Bads of the Endocannabinoid System as a Therapeutic Target: Lessons Learned after 30 Years
Mauro Maccarrone, Vincenzo Di Marzo, Jürg Gertsch, et al.
Pharmacological Reviews (2023) Vol. 75, Iss. 5, pp. 885-958
Open Access | Times Cited: 83
Targeting Cannabinoid Signaling in the Immune System: “High”-ly Exciting Questions, Possibilities, and Challenges
Attila Oláh, Zoltán Szekanecz, Tamás Bı́ró
Frontiers in Immunology (2017) Vol. 8
Open Access | Times Cited: 118
The endocannabinoid system and its therapeutic exploitation in multiple sclerosis: Clues for other neuroinflammatory diseases
Valerio Chiurchiù, Mario van der Stelt, Diego Centonze, et al.
Progress in Neurobiology (2017) Vol. 160, pp. 82-100
Open Access | Times Cited: 116
The Endocannabinoid System as a Target in Cancer Diseases: Are We There Yet?
Estefanía Moreno, Milena Čavić, Ana Krivokuća, et al.
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 109
Monoacylglycerol lipase (MAGL) as a promising therapeutic target
Ana Gil-Ordóñez, Mar Martı́n-Fontecha, Silvia Ortega‐Gutiérrez, et al.
Biochemical Pharmacology (2018) Vol. 157, pp. 18-32
Closed Access | Times Cited: 103
Endocannabinoid System Components as Potential Biomarkers in Psychiatry
Francisco Navarrete, María S. García‐Gutiérrez, Rosa Jurado‐Barba, et al.
Frontiers in Psychiatry (2020) Vol. 11
Open Access | Times Cited: 102
Enhanced endocannabinoid tone as a potential target of pharmacotherapy
Marek Toczek, Barbara Malinowska
Life Sciences (2018) Vol. 204, pp. 20-45
Closed Access | Times Cited: 95
Neurobiology of cannabinoid receptor signaling
Beat Lutz
Dialogues in Clinical Neuroscience (2020) Vol. 22, Iss. 3, pp. 207-222
Open Access | Times Cited: 79
Targeting Endocannabinoid Signaling: FAAH and MAG Lipase Inhibitors
Noëlle van Egmond, Verena M. Straub, Mario van der Stelt
The Annual Review of Pharmacology and Toxicology (2020) Vol. 61, Iss. 1, pp. 441-463
Open Access | Times Cited: 78
Recent Applications of Diazirines in Chemical Proteomics
Matthew W. Halloran, Jean‐Philip Lumb
Chemistry - A European Journal (2018) Vol. 25, Iss. 19, pp. 4885-4898
Closed Access | Times Cited: 68
Uncovering the psychoactivity of a cannabinoid from liverworts associated with a legal high
Andrea Chicca, Michael A. Schafroth, Inés Reynoso-Moreno, et al.
Science Advances (2018) Vol. 4, Iss. 10
Open Access | Times Cited: 63
The Application of Fluorine‐Containing Reagents in Structural Proteomics
Ming Cheng, Chunyang Guo, Michael L. Gross
Angewandte Chemie International Edition (2019) Vol. 59, Iss. 15, pp. 5880-5889
Open Access | Times Cited: 63
Cannabinoid interventions for PTSD: Where to next?
Luke J. Ney, Allison Matthews, Raimondo Bruno, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2019) Vol. 93, pp. 124-140
Closed Access | Times Cited: 61
Endocannabinoid-Based Therapies
Daniele Piomelli, Alex Mabou Tagne
The Annual Review of Pharmacology and Toxicology (2021) Vol. 62, Iss. 1, pp. 483-507
Open Access | Times Cited: 51
Δ9-cis-Tetrahydrocannabinol: Natural Occurrence, Chirality, and Pharmacology
Michael A. Schafroth, Giulia Mazzoccanti, Inés Reynoso-Moreno, et al.
Journal of Natural Products (2021) Vol. 84, Iss. 9, pp. 2502-2510
Open Access | Times Cited: 47
Endocannabinoid signaling in brain diseases: Emerging relevance of glial cells
Ana Bernal‐Chico, Vanja Tepavčević, Andrea Manterola, et al.
Glia (2022) Vol. 71, Iss. 1, pp. 103-126
Open Access | Times Cited: 29
Optimization of a Benzoylpiperidine Class Identifies a Highly Potent and Selective Reversible Monoacylglycerol Lipase (MAGL) Inhibitor
Carlotta Granchi, Margherita Lapillo, Sandra Glasmacher, et al.
Journal of Medicinal Chemistry (2019) Vol. 62, Iss. 4, pp. 1932-1958
Open Access | Times Cited: 53
Discovery of 1,5-Diphenylpyrazole-3-Carboxamide Derivatives as Potent, Reversible, and Selective Monoacylglycerol Lipase (MAGL) Inhibitors
Mojgan Aghazadeh Tabrizi, Pier Giovanni Baraldi, Stefania Baraldi, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 3, pp. 1340-1354
Open Access | Times Cited: 51
The endocannabinoid system in modulating fear, anxiety, and stress
Rafaël Maldonado, David Cabañero, Elena Martín‐García
Dialogues in Clinical Neuroscience (2020) Vol. 22, Iss. 3, pp. 229-239
Open Access | Times Cited: 48
The ACSL3-LPIAT1 signaling drives prostaglandin synthesis in non-small cell lung cancer
Maria Saliakoura, Inés Reynoso-Moreno, Chiara Pozzato, et al.
Oncogene (2020) Vol. 39, Iss. 14, pp. 2948-2960
Open Access | Times Cited: 44
Anxiolytic effects of endocannabinoid enhancing compounds: A systematic review and meta-analysis
C. Kwee, N.A. Leen, Rian C. Van der Kamp, et al.
European Neuropsychopharmacology (2023) Vol. 72, pp. 79-94
Open Access | Times Cited: 14
Bridging the gap: The endocannabinoid system as a functional fulcrum for benzodiazepines in a novel frontier of anxiety pharmacotherapy
Sina Pakkhesal, Mohammad Shakouri, Reza Mosaddeghi-Heris, et al.
Pharmacology & Therapeutics (2025), pp. 108799-108799
Closed Access
Page 1 - Next Page

Scroll to top